AAAAAA
Results:
1-7
|
Results: 7
Authors:
Vardy, D
Barenholz, Y
Naftoliev, N
Klaus, S
Gilead, L
Frankenburg, S
Citation: D. Vardy et al., Efficacious topical treatment for human cutaneous leishmaniasis with ethanolic lipid amphotericin B, T RS TROP M, 95(2), 2001, pp. 184-186
Authors:
Klaus, SN
Frankenburg, S
Ingber, A
Citation: Sn. Klaus et al., Epidemiology of cutaneous leishmaniasis, CLIN DERMAT, 17(3), 1999, pp. 257-260
Authors:
Klaus, S
Frankenburg, S
Citation: S. Klaus et S. Frankenburg, Cutaneous leishmaniasis in the Middle East, CLIN DERMAT, 17(2), 1999, pp. 137-141
Authors:
Golenser, J
Frankenburg, S
Ehrenfreund, T
Domb, AJ
Citation: J. Golenser et al., Efficacious treatment of experimental leishmaniasis with amphotericin B-arabinogalactan water-soluble derivatives, ANTIM AG CH, 43(9), 1999, pp. 2209-2214
Authors:
Vardy, DA
Cohen, A
Kachko, L
Zvulunov, A
Frankenburg, S
Citation: Da. Vardy et al., Relapse of cutaneous leishmaniasis in a patient with an infected subcutaneous rheumatoid nodule, BR J DERM, 141(5), 1999, pp. 914-917
Authors:
Vardy, D
Barenholz, Y
Cohen, R
Zvulunov, A
Biton, A
Klaus, S
Frankenburg, S
Citation: D. Vardy et al., Topical amphotericin B for cutaneous leishmaniasis, ARCH DERMAT, 135(7), 1999, pp. 856-857
Authors:
Frankenburg, S
Glick, D
Klaus, S
Barenholz, Y
Citation: S. Frankenburg et al., Efficacious topical treatment for murine cutaneous leishmaniasis with ethanolic formulations of amphotericin B, ANTIM AG CH, 42(12), 1998, pp. 3092-3096
Risultati:
1-7
|